Scandinavian ChemoTech presents IQwave™ and D-EECT at the upcoming European Oncology Convention
ChemoTech is proud to announce its first presence in a European medical conference. This will take place during The European Oncology Convention in Birmingham UK the 26-27th of March 2019.
The European Oncology Convention in Birmingham will also be the first time that ChemoTechs co-founder and inventor will present the data and findings from the article that was published last year.
Speaker: Bertil Persson Prof em Radio Physics Lund University, Sweden
Date and time: 27th of March 2019 at 14:45
- We are very pleased to have secured a seminar spot during this conference. We are also happy that we are able to present the clinical data as well as show IQwave™ to the European Market, says Mohan Frick CEO who personally will be present during the conference.
For more information about the conference please visit their website: http://www.oncologyconvention.com/
ChemoTechs IQwave™ Electroporation Device and its accessories are only available and marked in Philippines and India. IQwave™ is not approved for sale by the FDA in USA
For more info, please contact:
Mohan Frick, VD
Tele: +46 (0)10-218 93 00
Certified Adviser: Västra Hamnen Corporate Finance AB, Tel: +46 40 200 250,
Scandinavian ChemoTech AB (publ)
www.chemotech.seChemoTech is a life science company that possesses great medical expertise and technical knowledge. Our latest Product IQwave™ is an innovation within electroporation, specifically design for Electrochemotherapy for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered at Medicon Village in Lund Sweden, in the midst of the medical technology expansionary Oresund region.